Guest guest Posted February 10, 2004 Report Share Posted February 10, 2004 Believe me Mark they have already seen it. M. Faenza, President and CEO of NMHA, is a pawn of a $37B machine called big pharma. The FDA wants more time to study the data while kids are dying. This is what they asked for back in 1991. It's too bad didn't report what really happened at the FDA meeting. Maybe he fell asleep at the meeting or didn't read any significant newspaper like the NY Times the next day or both. Mark Heyrman <mheyrman@...> wrote: see below hope you will circulate this to your friends Makr NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for Youth NMHA Statement to the Media February 2, 2004 NMHA Lauds FDA Safety Review of Antidepressants for Youth Calls for Attention to Public Health Crisis of Untreated Mental Disorders in Children A Statement by M. Faenza, President and CEO of NMHA Contact: Cobb 703-797-2588 hcobb@... ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health Association commends the Food and Drug Administration for initiating a review today of the clinical use of antidepressant medications in youth. More scientific research is needed on the safety of all medications prescribed to children. Traditionally, very little research has been done on children and medications - including those commonly used to treat physical illnesses. Yet, there is no question that SSRIs, like medications used to treat physical disease, are crucial in treating serious and potentially life-threatening illnesses. The safety issue is not one to be ignored. However, we cannot let the discussion about antidepressant medication overshadow the public health crisis of untreated mental disorders in children. In this nation, only one-third of children needing mental health treatment receive it, and even fewer receive appropriate care. Depression alone affects one in 33 children and one in eight adolescents. By failing to provide appropriate treatments and interventions to children with mental or emotional disorders, we risk harming their social and educational development, which can lead to academic failure, substance abuse problems or involvement in the juvenile justice system. In fact, 80 percent of young people in the juvenile justice system have a mental or substance abuse disorder, according to a report of the President's New Freedom Commission on Mental Health. Parents of children with mental health problems face incredible barriers to getting needed treatment, including fragmented service systems, primary care providers who lack specialized training, too few pediatric mental health specialists, insurance obstacles in both public and private plans, a lack of quality school programs and trained personnel, complex policies obstructing access to needed treatment, including medications, and - perhaps the worst of all - stigma. The stigma surrounding mental illness is an enormous factor limiting families' ability to obtain effective services. Misinformation dissuades parents from seeking proven treatments for their children. And stigma and lack of information contribute to the misperception that we are " drugging our children. " In reality, children and their families need access to a broad range of services, which for some children may include medication. We call on FDA to guard against overreaction. We urge that the needs and best interests of children not be swept aside by shrill calls - some from those who deny that mental illness even exists - for sweeping action that would deprive children of access to treatment and support. NMHA believes that the approach to antidepressant medications for youth with major depressive disorder must be measured. We must ensure that treatments for children are safe and effective through increased research and the sharing of all clinical findings. And we must be mindful of the many, many children with mental health needs who benefit greatly from these medications. The National Mental Health Association is the country's oldest and largest nonprofit organization addressing all aspects of mental health and mental illness. With more than 340 affiliates nationwide, NMHA works to improve the mental health of all Americans through advocacy, education, research and service. ### F. Prior jprior@... Chicago, IL 60656-1639 Calendar: http://calendar./j_prior Cell: 773/230-5825 Fax: 781/459-8592 : 22:36-40 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 10, 2004 Report Share Posted February 10, 2004 Believe me Mark they have already seen it. M. Faenza, President and CEO of NMHA, is a pawn of a $37B machine called big pharma. The FDA wants more time to study the data while kids are dying. This is what they asked for back in 1991. It's too bad didn't report what really happened at the FDA meeting. Maybe he fell asleep at the meeting or didn't read any significant newspaper like the NY Times the next day or both. Mark Heyrman <mheyrman@...> wrote: see below hope you will circulate this to your friends Makr NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for Youth NMHA Statement to the Media February 2, 2004 NMHA Lauds FDA Safety Review of Antidepressants for Youth Calls for Attention to Public Health Crisis of Untreated Mental Disorders in Children A Statement by M. Faenza, President and CEO of NMHA Contact: Cobb 703-797-2588 hcobb@... ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health Association commends the Food and Drug Administration for initiating a review today of the clinical use of antidepressant medications in youth. More scientific research is needed on the safety of all medications prescribed to children. Traditionally, very little research has been done on children and medications - including those commonly used to treat physical illnesses. Yet, there is no question that SSRIs, like medications used to treat physical disease, are crucial in treating serious and potentially life-threatening illnesses. The safety issue is not one to be ignored. However, we cannot let the discussion about antidepressant medication overshadow the public health crisis of untreated mental disorders in children. In this nation, only one-third of children needing mental health treatment receive it, and even fewer receive appropriate care. Depression alone affects one in 33 children and one in eight adolescents. By failing to provide appropriate treatments and interventions to children with mental or emotional disorders, we risk harming their social and educational development, which can lead to academic failure, substance abuse problems or involvement in the juvenile justice system. In fact, 80 percent of young people in the juvenile justice system have a mental or substance abuse disorder, according to a report of the President's New Freedom Commission on Mental Health. Parents of children with mental health problems face incredible barriers to getting needed treatment, including fragmented service systems, primary care providers who lack specialized training, too few pediatric mental health specialists, insurance obstacles in both public and private plans, a lack of quality school programs and trained personnel, complex policies obstructing access to needed treatment, including medications, and - perhaps the worst of all - stigma. The stigma surrounding mental illness is an enormous factor limiting families' ability to obtain effective services. Misinformation dissuades parents from seeking proven treatments for their children. And stigma and lack of information contribute to the misperception that we are " drugging our children. " In reality, children and their families need access to a broad range of services, which for some children may include medication. We call on FDA to guard against overreaction. We urge that the needs and best interests of children not be swept aside by shrill calls - some from those who deny that mental illness even exists - for sweeping action that would deprive children of access to treatment and support. NMHA believes that the approach to antidepressant medications for youth with major depressive disorder must be measured. We must ensure that treatments for children are safe and effective through increased research and the sharing of all clinical findings. And we must be mindful of the many, many children with mental health needs who benefit greatly from these medications. The National Mental Health Association is the country's oldest and largest nonprofit organization addressing all aspects of mental health and mental illness. With more than 340 affiliates nationwide, NMHA works to improve the mental health of all Americans through advocacy, education, research and service. ### F. Prior jprior@... Chicago, IL 60656-1639 Calendar: http://calendar./j_prior Cell: 773/230-5825 Fax: 781/459-8592 : 22:36-40 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 10, 2004 Report Share Posted February 10, 2004 All this concern about the children getting treatment and yet no mention that the drug companies studies have consistently found that the safest, most effective treatment for depression is the placebo. Maybe if they came up with a medication that actually worked....... > > see below > hope you will circulate this to your friends > Makr > > NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for Youth > > > > NMHA Statement to the Media > February 2, 2004 > > > > NMHA Lauds FDA Safety Review of Antidepressants for Youth > Calls for Attention to Public Health Crisis of Untreated Mental Disorders in Children > > A Statement by M. Faenza, President and CEO of NMHA > > > > Contact: > > Cobb > 703-797-2588 > hcobb@n... > > > ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health Association commends the Food and Drug Administration for initiating a review today of the clinical use of antidepressant medications in youth. More scientific research is needed on the safety of all medications prescribed to children. Traditionally, very little research has been done on children and medications - including those commonly used to treat physical illnesses. Yet, there is no question that SSRIs, like medications used to treat physical disease, are crucial in treating serious and potentially life-threatening illnesses. > > The safety issue is not one to be ignored. However, we cannot let the discussion about antidepressant medication overshadow the public health crisis of untreated mental disorders in children. In this nation, only one-third of children needing mental health treatment receive it, and even fewer receive appropriate care. > > Depression alone affects one in 33 children and one in eight adolescents. By failing to provide appropriate treatments and interventions to children with mental or emotional disorders, we risk harming their social and educational development, which can lead to academic failure, substance abuse problems or involvement in the juvenile justice system. In fact, 80 percent of young people in the juvenile justice system have a mental or substance abuse disorder, according to a report of the President's New Freedom Commission on Mental Health. > > Parents of children with mental health problems face incredible barriers to getting needed treatment, including fragmented service systems, primary care providers who lack specialized training, too few pediatric mental health specialists, insurance obstacles in both public and private plans, a lack of quality school programs and trained personnel, complex policies obstructing access to needed treatment, including medications, and - perhaps the worst of all - stigma. > > The stigma surrounding mental illness is an enormous factor limiting families' ability to obtain effective services. Misinformation dissuades parents from seeking proven treatments for their children. And stigma and lack of information contribute to the misperception that we are " drugging our children. " In reality, children and their families need access to a broad range of services, which for some children may include medication. > > We call on FDA to guard against overreaction. We urge that the needs and best interests of children not be swept aside by shrill calls - some from those who deny that mental illness even exists - for sweeping action that would deprive children of access to treatment and support. > > NMHA believes that the approach to antidepressant medications for youth with major depressive disorder must be measured. We must ensure that treatments for children are safe and effective through increased research and the sharing of all clinical findings. And we must be mindful of the many, many children with mental health needs who benefit greatly from these medications. > > The National Mental Health Association is the country's oldest and largest nonprofit organization addressing all aspects of mental health and mental illness. With more than 340 affiliates nationwide, NMHA works to improve the mental health of all Americans through advocacy, education, research and service. > > ### > > > > > F. Prior jprior@w... Chicago, IL 60656-1639 > > Calendar: http://calendar./j_prior > > Cell: 773/230-5825 Fax: 781/459-8592 > > : 22:36-40 > > > > > > Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 10, 2004 Report Share Posted February 10, 2004 All this concern about the children getting treatment and yet no mention that the drug companies studies have consistently found that the safest, most effective treatment for depression is the placebo. Maybe if they came up with a medication that actually worked....... > > see below > hope you will circulate this to your friends > Makr > > NMHA Statement: NMHA Lauds FDA Safety Review of Antidepressants for Youth > > > > NMHA Statement to the Media > February 2, 2004 > > > > NMHA Lauds FDA Safety Review of Antidepressants for Youth > Calls for Attention to Public Health Crisis of Untreated Mental Disorders in Children > > A Statement by M. Faenza, President and CEO of NMHA > > > > Contact: > > Cobb > 703-797-2588 > hcobb@n... > > > ALEXANDRIA, Va. (February 2, 2004) - The National Mental Health Association commends the Food and Drug Administration for initiating a review today of the clinical use of antidepressant medications in youth. More scientific research is needed on the safety of all medications prescribed to children. Traditionally, very little research has been done on children and medications - including those commonly used to treat physical illnesses. Yet, there is no question that SSRIs, like medications used to treat physical disease, are crucial in treating serious and potentially life-threatening illnesses. > > The safety issue is not one to be ignored. However, we cannot let the discussion about antidepressant medication overshadow the public health crisis of untreated mental disorders in children. In this nation, only one-third of children needing mental health treatment receive it, and even fewer receive appropriate care. > > Depression alone affects one in 33 children and one in eight adolescents. By failing to provide appropriate treatments and interventions to children with mental or emotional disorders, we risk harming their social and educational development, which can lead to academic failure, substance abuse problems or involvement in the juvenile justice system. In fact, 80 percent of young people in the juvenile justice system have a mental or substance abuse disorder, according to a report of the President's New Freedom Commission on Mental Health. > > Parents of children with mental health problems face incredible barriers to getting needed treatment, including fragmented service systems, primary care providers who lack specialized training, too few pediatric mental health specialists, insurance obstacles in both public and private plans, a lack of quality school programs and trained personnel, complex policies obstructing access to needed treatment, including medications, and - perhaps the worst of all - stigma. > > The stigma surrounding mental illness is an enormous factor limiting families' ability to obtain effective services. Misinformation dissuades parents from seeking proven treatments for their children. And stigma and lack of information contribute to the misperception that we are " drugging our children. " In reality, children and their families need access to a broad range of services, which for some children may include medication. > > We call on FDA to guard against overreaction. We urge that the needs and best interests of children not be swept aside by shrill calls - some from those who deny that mental illness even exists - for sweeping action that would deprive children of access to treatment and support. > > NMHA believes that the approach to antidepressant medications for youth with major depressive disorder must be measured. We must ensure that treatments for children are safe and effective through increased research and the sharing of all clinical findings. And we must be mindful of the many, many children with mental health needs who benefit greatly from these medications. > > The National Mental Health Association is the country's oldest and largest nonprofit organization addressing all aspects of mental health and mental illness. With more than 340 affiliates nationwide, NMHA works to improve the mental health of all Americans through advocacy, education, research and service. > > ### > > > > > F. Prior jprior@w... Chicago, IL 60656-1639 > > Calendar: http://calendar./j_prior > > Cell: 773/230-5825 Fax: 781/459-8592 > > : 22:36-40 > > > > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.